[SYRE] YoY Annual Result on 31-Dec-2018 [#FY]

Stock
[SYRE] Spyre Therapeutics, Inc.
Announcement Date
29-Dec-2018
Financial Year
2018
Quarter
31-Dec-2018 [#FY]
Profit Trend
YoY- -62.83%
Quarter Report
SYRE's Result
SYRE's Financial Summary
View:
Show?
Annual Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 2,329 18,739 0 0 3,888 5,205 4,628 -10.80%
PBT -83,951 -65,660 -80,893 -78,254 -44,348 -27,236 -21,698 25.28%
Tax -136 141 -593 0 0 0 0 -
NP -83,815 -65,801 -80,893 -78,254 -44,348 -27,236 -21,698 25.24%
Tax Rate - - - - - - - -
Total Cost 86,144 84,540 80,893 78,254 48,236 32,441 26,326 21.83%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -3,598.75 -351.14 0.00 0.00 -1,140.64 -523.27 -468.84 40.42%
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -24.86 -25.02 -37.89 -61.23 -53.25 -45.01 -55.40 -12.49%
EPS Diluted -24.86 -25.02 -37.89 -61.23 -53.25 -45.01 -55.40 -12.49%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.